The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Anemia Drugs Market In 2026 And What Value Is Projected For 2030?
The anemia drugs market has shown strong expansion in recent years. Its valuation is projected to increase from $15.77 billion in 2025 to $16.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. This historical growth can be linked to factors such as the prevalence of iron deficiency, the rise in chronic kidney disease, the utilization of hospital transfusions, the occurrence of maternal anemia, and dietary deficiencies.
The anemia drugs market size is projected to experience robust expansion in the coming years. It is anticipated to grow to $22.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period is attributable to factors like the expanding aging population, enhanced management of anemia in chronic diseases, the adoption of injectable iron, the broadening scope of home healthcare, and a focus on preventive supplementation. Significant trends for the forecast period encompass an increasing utilization of erythropoiesis-stimulating agents, the rise of intravenous iron therapy, the expansion of home-based anemia management services, a heightened focus on chronic disease-related anemia, and a transition towards combination supplement therapies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24141&type=smp
What Drivers Are Influencing The Anemia Drugs Market?
A rising emphasis on personalized medicine is projected to stimulate the expansion of the anemia drugs market moving forward. This medical approach customizes treatment and healthcare decisions according to an individual’s genetic makeup, lifestyle, and environment. The increased focus on personalized medicine is attributable to advancements in genomic sequencing, which enable more precise identification of individual genetic variations linked to disease and treatment response. Personalized medicine supports the production of anemia drugs by allowing for tailored treatments based on individual genetic profiles, thereby enhancing drug efficacy and minimizing adverse effects for better patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for patients with rare diseases, a significant increase from 6 in 2022. Therefore, the increasing focus on personalized medicine is a key driver for the growth of the anemia drugs market.
What Are The Key Segments Of The Anemia Drugs Market?
The anemia drugs market covered in this report is segmented –
1) By Drug Type: Dietary Supplements, Medicines
2) By Therapy Type: Oral Iron Therapy, Red Blood Cell Transfusion, Parental Iron Therapy, Other Therapy Types
3) By Anemia Type: Iron Deficiency Anemia, Sickle Cell Anemia, Aplastic Anemia, Hemolytic Anemia, Pernicious Anemia, Other Anemia Types
4) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy
5) By End-User: Clinic, Healthcare, Home Healthcare
Subsegments:
1) By Dietary Supplements: Iron Supplements, Vitamin B12 Supplements, Folic Acid Supplements, Multivitamin And Mineral Supplements
2) By Medicines: Erythropoiesis-Stimulating Agents (ESAs), Iron Chelating Agents, Corticosteroids, Immunosuppressants, Luspatercept And Related Agents
What Key Trends Are Influencing The Development Of The Anemia Drugs Market?
Major companies in the anemia drugs market are concentrating on groundbreaking drug advancements, such as oral HIF-PHI (hypoxia-inducible factor prolyl hydroxylase inhibitors), to better manage iron metabolism and boost red blood cell production for more potent anemia therapies. Oral HIF-PHI (Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors) constitute a category of oral medicines designed to target and suppress prolyl hydroxylase enzymes, which are key regulators of the hypoxia-inducible factor (HIF) pathway. For example, in February 2023, GSK plc, a pharmaceutical company based in the UK, unveiled Jesduvroq, a medication developed to improve red blood cell generation and address anemia in adult patients afflicted with chronic kidney disease. This pioneering anemia drug system is characterized by enhanced iron metabolism, elevated red blood cell production, and personalized treatment approaches. Jesduvroq proves highly effective, stimulating red blood cell production and mitigating anemia in chronic kidney disease patients by enhancing iron metabolism, thus leading to improved treatment outcomes.
Who Are The Leading Companies Operating In The Anemia Drugs Market?
Major companies operating in the anemia drugs market are Pfizer Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Fresenius SE & Co. KGaA, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Biocon Limited, Akebia Therapeutics Inc., Apellis Pharmaceuticals Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, Covis Pharma GmbH, AdvaCare Pharma LLC, BioLineRx Ltd., Bluebird Bio Inc.
Read the full anemia drugs market report here:
https://www.thebusinessresearchcompany.com/report/anemia-drugs-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Anemia Drugs Market?
North America was the largest region in the anemia drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anemia Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24141&type=smp
Browse Through More Reports Similar to the Global Anemia Drugs Market 2026, By The Business Research Company
Anemia And Other Blood Disorder Drugs Market Report 2026
Chemotherapy Induced Anemia Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report
Hematology Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model